Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,319
Sort by:
2017 Malta Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities for Suppliers
US$ 3,825.00
... , including: Infectious Diseases - Forensic Testing Cancer - Paternity Testing/HLA Typing Genetic Diseases - Others Five-year test volume and sales projections for ... of leading molecular diagnosticanalyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...
March 2017
1120 pages
2017 Netherlands Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities for Suppliers
US$ 3,825.00
... , including: Infectious Diseases - Forensic Testing Cancer - Paternity Testing/HLA Typing Genetic Diseases - Others Five-year test volume and sales projections for ... of leading molecular diagnosticanalyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...
March 2017
1120 pages
2017 Norway Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities for Suppliers
US$ 3,825.00
... , including: Infectious Diseases - Forensic Testing Cancer - Paternity Testing/HLA Typing Genetic Diseases - Others Five-year test volume and sales projections for ... of leading molecular diagnosticanalyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...
March 2017
1120 pages
2017 Poland Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities for Suppliers
US$ 3,825.00
... , including: Infectious Diseases - Forensic Testing Cancer - Paternity Testing/HLA Typing Genetic Diseases - Others Five-year test volume and sales projections for ... of leading molecular diagnosticanalyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...
March 2017
1120 pages
2017 Portugal Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities for Suppliers
US$ 3,825.00
... , including: Infectious Diseases - Forensic Testing Cancer - Paternity Testing/HLA Typing Genetic Diseases - Others Five-year test volume and sales projections for ... of leading molecular diagnosticanalyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...
March 2017
1120 pages
2017 Romania Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities for Suppliers
US$ 3,825.00
... , including: Infectious Diseases - Forensic Testing Cancer - Paternity Testing/HLA Typing Genetic Diseases - Others Five-year test volume and sales projections for ... of leading molecular diagnosticanalyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...
March 2017
1120 pages
2017 Slovakia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities for Suppliers
US$ 3,825.00
... , including: Infectious Diseases - Forensic Testing Cancer - Paternity Testing/HLA Typing Genetic Diseases - Others Five-year test volume and sales projections for ... of leading molecular diagnosticanalyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...
March 2017
1120 pages
2017 Slovenia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities for Suppliers
US$ 3,825.00
... , including: Infectious Diseases - Forensic Testing Cancer - Paternity Testing/HLA Typing Genetic Diseases - Others Five-year test volume and sales projections for ... of leading molecular diagnosticanalyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...
March 2017
1120 pages
2017 Sweden Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities for Suppliers
US$ 3,825.00
... , including: Infectious Diseases - Forensic Testing Cancer - Paternity Testing/HLA Typing Genetic Diseases - Others Five-year test volume and sales projections for ... of leading molecular diagnosticanalyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...
March 2017
1120 pages
2017 Switzerland Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities for Suppliers
US$ 3,825.00
... , including: Infectious Diseases - Forensic Testing Cancer - Paternity Testing/HLA Typing Genetic Diseases - Others Five-year test volume and sales projections for ... of leading molecular diagnosticanalyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...
March 2017
1120 pages
2017 Portugal Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... . Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, ... risks. Cancer Diagnostic Tests Analyzed in the Report--over 200 current and emerging assays, including Biochemical Markers, Oncogenes, Growth ...
March 2017
535 pages
2017 Austria Automated Microbiology Market: Molecular Diagnostics, Identification, Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics-- Specimen, Test, and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... microbiology market. Global listings of companies developing or marketing microbiology products by individual test. Competitive Assessments Strategic assessments of major suppliers and emerging market ...
March 2017
500 pages
2017 Belgium Automated Microbiology Market: Molecular Diagnostics, Identification, Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics-- Specimen, Test, and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... microbiology market. Global listings of companies developing or marketing microbiology products by individual test. Competitive Assessments Strategic assessments of major suppliers and emerging market ...
March 2017
500 pages
2017 Bulgaria Automated Microbiology Market: Molecular Diagnostics, Identification, Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics-- Specimen, Test, and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... microbiology market. Global listings of companies developing or marketing microbiology products by individual test. Competitive Assessments Strategic assessments of major suppliers and emerging market ...
March 2017
500 pages
2017 Canada Automated Microbiology Market: Molecular Diagnostics, Identification, Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics-- Specimen, Test, and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... microbiology market. Global listings of companies developing or marketing microbiology products by individual test. Competitive Assessments Strategic assessments of major suppliers and emerging market ...
March 2017
500 pages
2017 Cyprus Automated Microbiology Market: Molecular Diagnostics, Identification, Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics-- Specimen, Test, and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... microbiology market. Global listings of companies developing or marketing microbiology products by individual test. Competitive Assessments Strategic assessments of major suppliers and emerging market ...
March 2017
500 pages
2017 Czech Republic Automated Microbiology Market: Molecular Diagnostics, Identification, Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics-- Specimen, Test, and Sales Forecasts, Competitive Strategies, Opportunities
US$ 4,365.00
... of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems.The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been ...
March 2017
500 pages
